Sanofi and DN­Di aim to elim­i­nate sleep­ing sick­ness in Africa with promis­ing Ph II/III re­sults for new drug

The Drugs for Ne­glect­ed Dis­eases ini­tia­tive (DN­Di) and Sanofi to­day said that their po­ten­tial sleep­ing sick­ness treat­ment saw suc­cess rates of up to 95% from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER